Resonance [RESONANCE] vs Navin Fluorine [NAVINFLUOR] Detailed Stock Comparison
Resonance
BSE
Loading...
Navin Fluorine
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Resonance wins in 9 metrics, Navin Fluorine wins in 10 metrics, with 0 ties. Navin Fluorine appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Resonance | Navin Fluorine | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 17.74 | 67.38 | Resonance |
| Price-to-Book Ratio | 1.81 | 9.07 | Resonance |
| Debt-to-Equity Ratio | 13.66 | 55.85 | Resonance |
| PEG Ratio | N/A | 10.13 | N/A |
| EV/EBITDA | 11.24 | 38.80 | Resonance |
| Profit Margin (TTM) | 9.30% | 13.90% | Navin Fluorine |
| Operating Margin (TTM) | 10.45% | 23.65% | Navin Fluorine |
| EBITDA Margin (TTM) | 10.45% | 23.65% | Navin Fluorine |
| Return on Equity | 10.26% | 10.99% | Navin Fluorine |
| Return on Assets (TTM) | 8.69% | 5.97% | Resonance |
| Free Cash Flow (TTM) | $-40.70M | $40.40M | Navin Fluorine |
| Dividend Yield | 0.90% | 0.39% | Resonance |
| 1-Year Return | 1.21% | 45.10% | Navin Fluorine |
| Price-to-Sales Ratio (TTM) | 1.42 | 9.64 | Resonance |
| Enterprise Value | $1.27B | $248.46B | Navin Fluorine |
| EV/Revenue Ratio | 1.55 | 9.74 | Resonance |
| Gross Profit Margin (TTM) | 64.88% | 57.58% | Resonance |
| Revenue per Share (TTM) | $71 | $514 | Navin Fluorine |
| Earnings per Share (Diluted) | $5.65 | $71.24 | Navin Fluorine |
| Beta (Stock Volatility) | 0.71 | 0.23 | Navin Fluorine |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Resonance vs Navin Fluorine Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Resonance | 1.86% | -5.67% | -11.59% | 27.57% | 22.92% | 1.89% |
| Navin Fluorine | 1.62% | -5.43% | -1.68% | 10.43% | 19.37% | 49.24% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Resonance | 1.21% | -39.14% | 60.69% | 428.16% | 353.05% | 347.99% |
| Navin Fluorine | 45.10% | 12.33% | 129.97% | 1,651.50% | 8,728.00% | 7,377.53% |
Performance & Financial Health Analysis: Resonance vs Navin Fluorine
| Metric | RESONANCE | NAVINFLUOR |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.16B | ₹245.80B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 46,867 | 198,750 |
| 90 Day Avg. Volume | 29,358 | 141,252 |
| Last Close | ₹101.30 | ₹4,998.00 |
| 52 Week Range | ₹65.00 - ₹124.50 | ₹3,160.40 - ₹5,444.00 |
| % from 52W High | -18.63% | -8.19% |
| All-Time High | ₹254.95 (Sep 13, 2021) | ₹5,444.00 (Jul 31, 2025) |
| % from All-Time High | -60.27% | -8.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.23% | 0.39% |
| Quarterly Earnings Growth | 1.77% | 1.29% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.14% |
| Operating Margin (TTM) | 0.10% | 0.24% |
| Return on Equity (TTM) | 0.10% | 0.11% |
| Debt to Equity (MRQ) | 13.66 | 55.85 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹55.46 | ₹529.49 |
| Cash per Share (MRQ) | ₹0.20 | ₹99.88 |
| Operating Cash Flow (TTM) | ₹6.76M | ₹4.60B |
| Levered Free Cash Flow (TTM) | ₹65.66M | ₹2.89B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.90% | 0.39% |
| Last 12-Month Dividend | ₹1.00 | ₹19.00 |
Valuation & Enterprise Metrics Analysis: Resonance vs Navin Fluorine
| Metric | RESONANCE | NAVINFLUOR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 17.74 | 67.38 |
| Forward P/E | N/A | 40.11 |
| PEG Ratio | N/A | 10.13 |
| Price to Sales (TTM) | 1.42 | 9.64 |
| Price to Book (MRQ) | 1.81 | 9.07 |
| Market Capitalization | ||
| Market Capitalization | ₹1.16B | ₹245.80B |
| Enterprise Value | ₹1.27B | ₹248.46B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.55 | 9.74 |
| Enterprise to EBITDA | 11.24 | 38.80 |
| Risk & Other Metrics | ||
| Beta | 0.71 | 0.23 |
| Book Value per Share (MRQ) | ₹55.46 | ₹529.49 |
Financial Statements Comparison: Resonance vs Navin Fluorine
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RESONANCE | NAVINFLUOR |
|---|---|---|
| Revenue/Sales | ₹212.74M | ₹7.25B |
| Cost of Goods Sold | ₹118.10M | ₹3.08B |
| Gross Profit | ₹94.64M | ₹4.18B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹22.24M | ₹1.72B |
| EBITDA | ₹27.78M | ₹2.21B |
| Pre-Tax Income | ₹23.72M | ₹1.55B |
| Income Tax | ₹7.42M | ₹379.40M |
| Net Income (Profit) | ₹16.30M | ₹1.17B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RESONANCE | NAVINFLUOR |
|---|---|---|
| Cash & Equivalents | ₹2.25M | ₹196.80M |
| Total Current Assets | ₹522.10M | ₹15.89B |
| Total Current Liabilities | ₹77.26M | ₹9.15B |
| Long-Term Debt | ₹22.35M | ₹10.67B |
| Total Shareholders Equity | ₹640.22M | ₹26.26B |
| Retained Earnings | ₹490.80M | ₹23.27B |
| Property, Plant & Equipment | ₹13.87M | ₹25.97B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RESONANCE | NAVINFLUOR |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | RESONANCE | NAVINFLUOR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 46,867 | 198,750 |
| Average Daily Volume (90 Day) | 29,358 | 141,252 |
| Shares Outstanding | 11.54M | 49.59M |
| Float Shares | 4.15M | 34.84M |
| % Held by Insiders | 0.65% | 0.29% |
| % Held by Institutions | 0.00% | 0.42% |
Dividend Analysis & Yield Comparison: Resonance vs Navin Fluorine
| Metric | RESONANCE | NAVINFLUOR |
|---|---|---|
| Last 12-Month Dividend | ₹1.00 | ₹19.00 |
| Last 12-Month Dividend Yield | 0.90% | 0.39% |
| 3-Year Avg Annual Dividend | ₹1.00 | ₹16.33 |
| 3-Year Avg Dividend Yield | 0.83% | 0.15% |
| 3-Year Total Dividends | ₹3.00 | ₹49.00 |
| Ex-Dividend Date | Jul 29, 2025 | Jul 04, 2025 |